Education
About Us
Working with TipRanks
Follow Us
BioMark Diagnostics (TSE:BUX)
:BUX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 154.22K | C$ 163.22K | C$ 153.49K | C$ 43.93K | C$ 0.00 |
| Gross Profit | C$ 154.22K | C$ 163.22K | C$ -232.70K | C$ 43.93K | C$ -13.69K |
| Operating Income | C$ -1.91M | C$ -1.32M | C$ -1.84M | C$ -1.28M | C$ -1.09M |
| EBITDA | C$ -1.46M | C$ -919.05K | C$ -1.35M | C$ -1.22M | C$ -1.08M |
| Net Income | C$ -1.93M | C$ -1.43M | C$ -1.84M | C$ -1.45M | C$ -1.09M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 2.48M | C$ 156.75K | C$ 72.04K | C$ 382.71K | C$ 877.68K |
| Total Assets | C$ 3.13M | C$ 1.09M | C$ 732.29K | C$ 1.47M | C$ 952.94K |
| Total Debt | C$ 454.16K | C$ 805.93K | C$ 823.87K | C$ 1.05M | C$ 119.32K |
| Net Debt | C$ -2.03M | C$ 649.18K | C$ 751.83K | C$ 666.69K | C$ -758.35K |
| Total Liabilities | C$ 1.39M | C$ 1.70M | C$ 1.88M | C$ 2.11M | C$ 1.03M |
| Stockholders' Equity | C$ 1.74M | C$ -609.61K | C$ -1.15M | C$ -635.69K | C$ -79.09K |
| Cash Flow | |||||
| Free Cash Flow | C$ -1.10M | C$ -986.91K | C$ -919.72K | C$ -1.26M | C$ -455.55K |
| Operating Cash Flow | C$ -1.09M | C$ -982.52K | C$ -914.42K | C$ -1.20M | C$ -455.55K |
| Investing Cash Flow | C$ -3.53K | C$ -4.39K | C$ -5.30K | C$ -59.20K | C$ -3.20K |
| Financing Cash Flow | C$ 3.42M | C$ 1.07M | C$ 609.05K | C$ 768.16K | C$ 724.63K |
BioMark Diagnostics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.